Podcasts about fda commissioner

Food addiction isn't about willpower.It's about biology.This week's guest, Dr. David A. Kessler, pulls back the curtain on GLP-1 drugs, the medications everyone's talking about but few truly understand. As a former FDA Commissioner, bestselling author of Diet, Drugs, and Dopamine, and someone who has personally used Ozempic, Dr. David reveals what pharmaceutical companies aren't telling you about how they actually work.David shares his own journey with GLP-1 medications, the science behind why they're so effective, and the critical conversations we're not having about safety, proper use, and what happens when you stop taking them.Through science, candor, and vulnerability, he explains:Why food addiction is real, and how it rewires the reward circuits of the brainHow GLP-1 drugs like Ozempic are changing the conversation about obesity and self-blameWhy “just eat less” doesn't work… and never didHow visceral fat creates an invisible storm of inflammation, starting in childhoodAnd what it means to actually change your relationship with food for goodDr Kessler doesn't offer a magic solution. He offers tools: from nutritional rewiring to behavioral insight, from emotional honesty to policy change.Ultimately, he reminds us that health isn't about being perfect. It's about understanding what drives us, learning how to interrupt the cycle, and reclaiming agency in a world designed to overwhelm it.Real healing isn't about restriction. It's about relief.It's not about weight. It's about freedom.Love,Sarah Ann

Why don't medical schools teach doctors about nutrition? New study adds to evidence that glyphosate can cause cancer; Former FDA chief calls for low-carb dietary guidelines; 2024 analysis shows saturated fat and cholesterol restriction ineffective for heart disease prevention; Natural support for the pain of vertebral compression fractures; Are “fruit and veggie” pills really as effective as they claim? Facial and neck massage facilitate brain's natural waste disposal, offering hope for neurodegenerative disorders.

Learn more about your ad choices. Visit podcastchoices.com/adchoices

Today's episode explores whether certain foods can be addictive, with insight from Dr. David Kessler, former FDA Commissioner and author of "Diet, Drugs, and Dopamine." Monica and Dr. Kessler discuss the concept of food addiction, compulsive eating, and the brain's reward system.Transcript: https://nutrition-diva.simplecast.com/episodes/can-we-really-be-addicted-to-food-with-dr-david-kessler/transcriptReferencesEvidence for sugar addiction: behavioral and neurochemical effects of intermittent, excessive sugar intake - PubMedAddiction-like reward dysfunction and compulsive eating in obese rats: Role for dopamine D2 receptors - PMCFemale mice are more prone to develop an addictive-like phenotype for sugar consumption | Scientific ReportsFrontiers | Shifts in naturalistic behaviors induced by early social isolation stress are associated with adult binge-like eating in female ratsAddictive Junk Food: A Simple Story for a Complex Problem - ConscienHealthChemical Complexity of Food and Implications for Therapeutics | New England Journal of Medicine New to Nutrition Diva? Check out our special Spotify playlist for a collection of the best episodes curated by our team and Monica herself! We've also curated some great playlists on specific episode topics including Diabetes and Gut Health! Also, find a playlist of our bone health series, Stronger Bones at Every Age. Have a nutrition question? Send an email to nutrition@quickanddirtytips.com. Follow Nutrition Diva on Facebook and subscribe to the newsletter for more diet and nutrition tips. Find Monica's blog and other programs at Nutrition Over Easy. Nutrition Diva is a part of the Quick and Dirty Tips podcast network. LINKS:Transcripts: https://nutrition-diva.simplecast.com/episodes/Facebook: https://www.facebook.com/QDTNutrition/Newsletter: https://www.quickanddirtytips.com/nutrition-diva-newsletterNutrition Over Easy: https://nutritionovereasy.comQuick and Dirty Tips: https://quickanddirtytipscom

This week on Face the Nation, the turmoil over tariffs continues. The economic whiplash from the on again, off again Trump tariffs persists here at home, as does the confusion around the world. We speak exclusively with Treasury Secretary Scott Bessent. Then, as Congress continues to move forward with its massive tax and border bill, questions remain on how the Senate will change it. Kentucky Republican Senator Rand Paul gives us the latest on what's next for the president's sweeping agenda and his criticisms of it.  Plus, how will the administration's new restrictions on foreign student visas impact America's colleges and universities -- and our ability to attract international talent to our workforce?  House Democrat Raja Krishnamoorthi and Wesleyan University President Michael Roth will be here to discuss. Finally, we'll get some clarity on whether or not healthy children and pregnant women should get the Covid-19 vaccine after a week of mixed messaging from Trump administration health officials. FDA Commissioner Marty Makary will join us to clear things up.  To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

In a significant shift this week, Health Secretary Robert F. Kennedy Jr. announced that COVID-19 vaccines will no longer be recommended for healthy children and pregnant individuals. That sparked concerns from some public health officials and medical professionals. But FDA Commissioner Dr. Martin Makary has defended the guidelines and joined Amna Nawaz to discuss why. PBS News is supported by - https://www.pbs.org/newshour/about/funders

Four years ago, Matthew “Whiz” Buckley crossed the border into Mexico with three fellow veterans and an NFL veteran—each seeking healing through psychedelic-assisted therapy after traditional methods failed to address the invisible wounds of war, trauma, and addiction.What began as a deeply personal journey has now become a national mission through the No Fallen Heroes Foundation. In this powerful episode of The MAX Afterburner Podcast, Whiz reflects on how far the movement has come—and how the past three weeks may represent a historic turning point for veteran mental health care in the United States.Highlights from the episode include:• A public cabinet-level briefing on the role of psychedelics and nonprofits in the future of veteran care• Whiz's in-person meeting with VA Secretary Collins in Washington, D.C., advocating for access, research, and reform• Updates from the federal summit on psychedelic medicine, bringing together scientists, policymakers, and veteran advocates• Breaking news: The FDA Commissioner confirms that exploring psychedelic medicine is a “top priority” for the Trump administration• The nomination of a new U.S. Surgeon General who claims psilocybin helped her heal and find loveThe episode closes with a forward-looking vision:Over the next four years, Whiz sees the rescheduling of psychedelic medicines, the creation of veteran vouchers, and stronger partnerships between the VA and nonprofit organizations delivering real-world outcomes.This episode is more than a reflection—it's a rally cry. The mission is clear: healing our heroes at home starts now.

-- On the Show: -- Brittany Page, host of the Page Perspective, fills in for David. Subscribe to her channel at http://www.youtube.com/@brittanyepage -- Trump posts an unhinged Memorial Day message on Truth Social and boasts about his successes in a speech at Arlington National Cemetery -- New York Post warns Trump his chaotic tariff policies risk alienating supporters and allies alike -- Pete Hegseth tightens media access at the Pentagon citing protection of intelligence and security secrets -- New Yorker reveals Don Jr's new exclusive $500K pay-to-play club granting direct access to Cabinet members -- Patty Murray tells FDA Commissioner she won't let the Trump administration secretly ban the abortion pill amid ongoing chaos -- Texas approves Ten Commandments in public schools; Dem Rep calls out GOP hypocrisy for voting on the Sabbath -- Trump renews attacks on Harvard over alleged antisemitism despite his administration's ties to extremists -- Trump's alma mater criticizes the weak House Reconciliation bill -- Trump pardons a sheriff convicted in a bribery scheme by jury verdict -- On the Bonus Show: Trump's press conference, FBI investigating cocaine found in White House under Biden, and much more...

In this week's episode of High on Home Grown, Macky flies solo to bring you the latest cannabis news from around the world: The FDA Commissioner under the Trump administration says exploring psychedelic medicine is a “top priority” moving forward. (Source: Marijuana Moment) Former footballer Jay Emmanuel-Thomas admits to plotting to smuggle £600k worth of cannabis. (Source: BBC News) The Texas House passes a bill banning the sale and possession of THC cannabis products, raising serious concerns for patients and hemp business owners. In a powerful ruling, modern slaves found in a UK cannabis farm have been acquitted, highlighting the human trafficking issues behind some illicit grows. (Source: Doughty Street Chambers) And in Canada, the cannabis industry is thriving—but budtenders say they're not being paid fairly, raising questions about wage equity in the booming sector. Join Macky for this solo deep dive into the week's biggest cannabis headlines and stories that matter to the global cannabis community. Come and join in the discussion about any of these news articles on our cannabis growing forum, Discord server, or any of your favourite social networks. Visit our website for links.  Website: https://highonhomegrown.com Discord: https://discord.gg/sqYGkF4xyQ Youtube: https://www.youtube.com/highonhomegrown Thank you for downloading and listening to our cannabis podcast! I hope you enjoy this episode.

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Pfizer has made a $6 billion bet on acquiring 3SBio's PD-1/VEGF antibody, despite being a late entrant to the space. This deal comes after Pfizer's partnership with Summit Therapeutics, causing some confusion about the pharma company's overall strategy. Meanwhile, the success of a CRISPR baby has highlighted the lack of FDA-approved treatments for the 15 million children with rare diseases. Most rare conditions do not even have a treatment pipeline. Bio-Rad is redefining antibody discovery through their Pioneer™ Antibody Discovery Platform, which accelerates programs and identifies clinical-quality candidates with industry-leading timelines. FDA Commissioner Marty Makary has expressed support for psychedelic therapies for neuropsychiatric conditions, noting significant benefits for patients. The most favored nation executive order issued by Trump may face legal challenges and unintended consequences for the healthcare sector and patient access. Overall, these developments in the pharmaceutical and biotech industries highlight ongoing challenges and opportunities in drug development and treatment for rare diseases.

Dr. Margaret (Peggy) Hamburg, former FDA Commissioner, describes the profound impact the HIV epidemic has had on her personally and in terms of her career choices. She discovered in her six years as FDA Commissioner how vitally important FDA is to the safety and protection of Americans, at home and abroad. FDA has oversight responsibility for fully 20% of the American economy. She is  deeply worried at the level of destruction visited upon FDA recently, but cautions that it is critical to wait until the dust has settled. “Corporate capture” of FDA has been an issue for a long time, tied to user fees and industry participation on advisory panels. What is most important is to engage the right expertise and experience, with effective guardrails. The Trump administration has instructed FDA to expand overseas unannounced inspections, expedite the creation of a centralized AI platform across all FDA units, and lower the barriers to the pharmaceutical industry building new facilities on US soil. In each of these ambitious goals, a step-by-step approach is needed, along with attention to the “disconnect” between big, new goals versus uncertain, or declining FDA capabilities in staff, financing, and dedicated offices. She is very concerned at the worsening threat to vaccines and the need somehow to earn back public trust. The same is true for the U.S. “biomedical research and innovation enterprise”—the envy of the world—that has been struck by a “wrecking ball.”

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.AbbVie, a pharmaceutical company, has criticized President Trump's drug pricing proposal despite reporting strong earnings this quarter. The company is facing challenges with declining sales of its drug Humira and a struggling aesthetics business. Meanwhile, Gilead is moving forward with the launch of its HIV drug despite macro pressures in the industry. FDA Commissioner Marty Makary's recent statements have been fact-checked, with some contradictions emerging.In other news, SpringWorks is potentially being bought out by Merck KGaA for $3.5 billion. Wacker Biotech is offering services for advanced therapies. Stay tuned for more updates on these developments in the pharmaceutical and biotech sectors.

Many conservatives want the FDA to impose tighter restrictions on mifepristone and misoprostol, which can be delivered by mail. The medication accounted for 63 percent of U.S. abortions in 2023. Amna Nawaz spoke with the new FDA commissioner, Dr. Marty Makary, about what the agency may do. PBS News is supported by - https://www.pbs.org/newshour/about/funders

Many conservatives want the FDA to impose tighter restrictions on mifepristone and misoprostol, which can be delivered by mail. The medication accounted for 63 percent of U.S. abortions in 2023. Amna Nawaz spoke with the new FDA commissioner, Dr. Marty Makary, about what the agency may do. PBS News is supported by - https://www.pbs.org/newshour/about/funders

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. In a recent interview with former Fox News journalist Megyn Kelly, FDA Commissioner Marty Makary discussed a potential new mechanism-driven pathway for expedited rare disease approvals, as well as the possibility of certain environmental factors contributing to autism. Despite Makary's announcement of a directive to limit industry participation in the FDA's advisory committees, industry involvement is actually required by a 1997 law, and banning industry representatives would not have a significant impact. Additionally, the FDA recently approved Sanofi/Regeneron's Dupixent for chronic hives after initially rejecting it, and Lilly has promised to manufacture a weight-loss pill in the US following a Phase III win. The newsletter also includes other news stories, opinions, and upcoming events in the biopharmaceutical industry.

About this episode: Last week, the Department of Health and Human Services abruptly fired around 10,000 employees, 3,500 of which were within the FDA alone—an organization of around 18,000 total employees as of January 2025. In this episode: A look at the work of the FDA and how it may be hampered by such significant cuts, and how patients may be among those most impacted. Guest: Dr. Robert Califf served as the FDA Commissioner under Presidents Barack Obama and Joe Biden. Host: Dr. Josh Sharfstein is vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg School of Public Health, a faculty member in health policy, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: Dr. Peter Marks's Resignation Letter (PDF)—The New York Times Widespread firings start at federal health agencies including many in leadership—NPR Shots The U.S. Food Safety System—Public Health On Call (June 2022) FDA Commissioner Dr. Robert Califf on Bivalent COVID-19 Vaccines, Combating Misinformation, and Building Trust—Public Health On Call (August 2022) Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

In this riveting episode of The 1000 Hours Outside Podcast, Ginny Yurich welcomes Dr. Marty Makary, the newly appointed FDA Commissioner, Johns Hopkins surgeon, and bestselling author, to uncover the uncomfortable truths hiding in plain sight within modern medicine. From the explosion of peanut allergies caused by outdated guidelines, to the damaging impact of smartphones on kids' mental health, to the silent assault on our microbiomes through overprescribed antibiotics and unnecessary C-sections, Dr. Makary pulls back the curtain on decades of medical dogma—and what it's costing our children. With insight, humility, and rare courage, he equips parents to ask better questions, trust their instincts, and demand a healthcare culture that values transparency over tradition. Together, Ginny and Dr. Makary dive into the heart of his books Blind Spots and The Price We Pay, spotlighting how misplaced medical vigor, flawed consensus, and lack of accountability have created ripple effects still harming families today. But this episode doesn't just diagnose the problems—it delivers solutions. Learn what to do before you pay a hospital bill, how to approach antibiotics with wisdom, and why humility is the antidote to broken systems. It's a must-listen for every parent who wants to protect their children, navigate the noise, and reclaim their confidence in raising healthy, whole kids. ** Learn more about Dr. Marty Makary here Get your copy of Blind Spots here Get your copy of The Price We Pay here Learn more about your ad choices. Visit megaphone.fm/adchoices

Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith, Senior Editor Sue Sutter, and Editor-in-Chief Nielsen Hobbs discuss the issues that dominated the Senate confirmation hearing for US Food and Drug Administration Commissioner nominee Martin Makary, including vaccines (1:03) and mifepristone (14:45), as well as several questions that were not asked (23:31). They also consider the potential impact of his answers on the agency. More On These Topics From The Pink Sheet Makary Plans To Review Mifepristone Data, Raising Concerns Of Abortion Pill Access Rollbacks: https://insights.citeline.com/pink-sheet/agency-leadership/us-fda/makary-plans-to-review-mifepristone-data-raising-concerns-of-abortion-pill-access-rollbacks-24NTRIXLKJD23OKNBB5Z7UAFL4/ Senators Scrutinize US FDA Commissioner Nominee Makary Over VRBPAC Cancellation: https://insights.citeline.com/pink-sheet/agency-leadership/us-fda/senators-scrutinize-us-fda-commissioner-nominee-makary-over-vrbpac-cancellation-HVW5VNH55ZFUPBL64BK2VNOYJA/ Science Vs. Politics: Hearing Could Reveal Makary's Approach To Unusual Administration Involvement: https://insights.citeline.com/pink-sheet/agency-leadership/us-fda/science-vs-politics-hearing-could-reveal-makarys-approach-to-unusual-administration-involvement-LGWBJEWWNRCIXPVEJ4AEAJRLN4/

Tense arguments on House floor after voting to censure Rep. Al Green (D-TX), President Trump gives one month delay on tariffs on Mexico; Senate Democrats react to reports of a pending Presidential Executive Order to close down the Education Department; Congress passes bill to reverse Biden Administration archaeological assessment regulation for offshore drilling; FDA Commissioner nominee testifies on trust in science and rules for dispensing the abortion drug mifepristone; Steve Witkoff, Special Presidential Envoy to the Middle East on President Trump's "last warning" to Hamas to release hostages; Ukrainian President Zelensky meets European leaders on a military aid package. Learn more about your ad choices. Visit megaphone.fm/adchoices

America Out Loud PULSE with Dr. Peter McCullough – We break down his misleading claims, the rising excess mortality linked to mRNA vaccines, and the broader corruption within regulatory agencies. Beyond vaccines, we explore alarming trends in autism, the dangers of mass poultry culling driving up egg prices, and the pharmaceutical industry's revolving door with regulators. The discussion underscores the urgent need for...

America Out Loud PULSE with Dr. Peter McCullough – We break down his misleading claims, the rising excess mortality linked to mRNA vaccines, and the broader corruption within regulatory agencies. Beyond vaccines, we explore alarming trends in autism, the dangers of mass poultry culling driving up egg prices, and the pharmaceutical industry's revolving door with regulators. The discussion underscores the urgent need for...

Jason Wright has ended his tenure leading the NFL Washington Commanders and has joined Ariel Investments co-CEO Mellody Hobson in a women's sports investing venture. The venture, Project Level, is a part owner in the newest National Women's Soccer League franchise in Denver. The two leaders discuss investing in women's sports and betting on diversity in boardrooms to boost corporate bottom lines. Plus, President Trump's pick to lead the Department of Health and Human Services appeared on Capitol Hill for two intense days of confirmation hearings. Robert F. Kennedy Jr. answered Senator questions about Medicare, Medicaid, and vaccinations, but former FDA Commissioner and Pfizer board member Dr. Scott Gottlieb said RFK's responses showed a failure to fully grasp the fundamentals of the current healthcare system. Plus, the clock is ticking on President Trump's tariffs on Canada and Mexico. CNBC's Steve Liesman breaks down the economics of the plans.  Steve Liesman - 06:25Dr. Scott Gottlieb - 15:46Mellody Hobson & Jason Wright - 26:55

Positive vibes about biotech emanating from the Jefferies Healthcare Conference were overshadowed by the uncertainty that is ahead because of the result of the U.S. elections. On the latest BioCentury This Week, BioCentury's editors discuss how the unconventional cabinet nominations of the incoming Trump administration have cast a pall over what had been growing enthusiasm for the prospects of the biotech sector. Washington Editor Steve Usdin also discusses what the nomination of Marty Makary as the next FDA Commissioner could mean for the sector, and recaps the latest update on the Biosecure Act. The BioCentury editors also discuss which pharmas are in or out in making a challenge to Eli Lilly and Novo Nordisk in the obesity market.View full story: https://www.biocentury.com/article/65431900:00 - Introduction00:32 - Jefferies Conference Takeaways06:25 - Trump Nominations17:41 - Biosecure Act Update21:01 - Pharma in ObesityTo submit a question to BioCentury's editors, email the BioCentury This Week team at podcasts@biocentury.com.Reach us by sending a text

Get your LT PetClub InForce today: http://ltpetclub247.com/  —— Get your protection from EMF damages to your body: https://ftwproject.com/ref/532  ——————————— Protect your investments with And We Know http://andweknow.com/gold Or call 720-605-3900, Tell them “LT” sent you. ————————————————— *Our AWK Website: https://www.andweknow.com/ *The Patriot Light: https://thepatriotlight.com/ ➜ AWK Shirts and gifts: https://shop.andweknow.com/ *BOWLING BROS: Sons Bowling channel: https://www.youtube.com/@Bowling_Bros/videos ————————————————— President Trump just nominated Dr. Marty Makary for FDA Commissioner… https://t.me/TheStormHasArrived17/14341 Trump's Surgeon General pick https://x.com/17ThankQ/status/1861021366377459969 Dear Santa Movie Is Actually About Satan https://x.com/TNTJohn1717/status/1860989032466874413 A Lot Of Truth Coming Out These Days. She Is Spot On About Hollywood, The Fallen Angels, Mt Hermon & 333 https://x.com/TNTJohn1717/status/1860655224026779769 Donald Trump is expected to kick transgender troops out of US military as early as January 20th according to a new report from The Times. https://x.com/CollinRugg/status/1860830888600248324 Amaryllis Fox Kennedy is Robert Kennedy's daughter in law. Tucker Carlson reads her analysis of Ukraine and Russia.https://x.com/CitizenFreePres/status/1860957117399642536 TUCKER: "I am very concerned that the people who have hated Trump for eight years and run out of ways to destroy him ...https://x.com/TheChiefNerd/status/1860855911864230331 —— *DONATIONS SITE: https://bit.ly/2Lgdrh5   *Mail your gift to: And We Know 30650 Rancho California Rd STE D406-123 (or D406-126) Temecula, CA 92591   ➜ AWK Shirts and gifts: https://shop.andweknow.com/   ➜ And We Know Challenge Coins & Patriot Pins https://andweknow.com/ThePatriotPin/   ➜ Audio Bible https://www.biblegateway.com/audio/mclean/kjv/1John.3.16   Connect with us in the following ways: + DISCORD Fellows: https://discord.gg/kMt8R2FC4z

In this episode of Biotalk, Geoff Meyerson, CEO of Locust Walk, is joined by Andy Meyerson, Managing Director, and Daniel Brog, Senior Vice President, for an insightful discussion on the implications of the 2024 U.S. election results for the biotech industry. The conversation delves into: What Trump's victory could mean for the biotech sector. The potential impact on the HHS and FDA under RFK's leadership. How figures like Elon Musk and Vivek Ramaswamy might influence healthcare policy (DOGE dynamics). We take a balanced approach, covering the potential positive and negative outcomes, implications, and our perspectives on these topics. Our analysis is based on actual statements made and prior activities, focusing specifically on the impacts for biotech. While we aim to minimize bias, we acknowledge that personal perspectives inevitably influence conclusions. Please note this was recorded Friday, November 23, before the announcements of the FDA Commissioner, Surgeon General, and Head of the CDC later that day. Join us as we explore how these political outcomes could shape the future of biotech and healthcare innovation. We welcome your thoughts and look forward to engaging in further discussions as events unfold. Email us at ceo@locustwalk.com to share your insights or questions.Subscribe or follow Biotalk on Apple Podcasts | Spotify.

In this episode of Biotalk, Geoff Meyerson, CEO of Locust Walk, is joined by Andy Meyerson, Managing Director, and Daniel Brog, Senior Vice President, for an insightful discussion on the implications of the 2024 U.S. election results for the biotech industry. The conversation delves into: What Trump's victory could mean for the biotech sector. The potential impact on the HHS and FDA under RFK's leadership. How figures like Elon Musk and Vivek Ramaswamy might influence healthcare policy (DOGE dynamics). We take a balanced approach, covering the potential positive and negative outcomes, implications, and our perspectives on these topics. Our analysis is based on actual statements made and prior activities, focusing specifically on the impacts for biotech. While we aim to minimize bias, we acknowledge that personal perspectives inevitably influence conclusions. Please note this was recorded Friday, November 23, before the announcements of the FDA Commissioner, Surgeon General, and Head of the CDC later that day. Join us as we explore how these political outcomes could shape the future of biotech and healthcare innovation. We welcome your thoughts and look forward to engaging in further discussions as events unfold. Email us at ceo@locustwalk.com to share your insights or questions.Subscribe or follow Biotalk on Apple Podcasts | Spotify.

New FDA Commissioner with Meg and ChrisSee omnystudio.com/listener for privacy information.

In this video, we dive into some jaw-dropping results from a new study that's shaking up the world of AI and medicine. Turns out, PD, an AI language model, absolutely crushed it with a 98% score on 50 questions from the USMLE Step 3 medical licensing exam! That's right—this AI beat out heavyweights like Claude, Gemini, Grok, and Hugging Chat/Slash Llama. We've got Dr. Scott Gottlieb, former FDA Commissioner and CNBC contributor, breaking it all down for us. He reveals a shocking fact: doctors only need a 60% to pass their exams. What's going on there? We also explore how these AI models are more like supercharged search engines rather than true medical experts. While AI can spit out answers like a pro, it doesn't mean it's ready to perform brain surgery anytime soon. But that's not all—we're also diving into some recent stock analysis. We look at Microsoft's performance based on OVTLYR's buy and sell signals. From a solid buy signal on June 14th to a sell signal on July 15th, Microsoft saw a nice 2.5% gain, or about $11 per share. OVTLYR's signals delivered a 113% return, showing just how powerful these tools can be. So, if you're curious about the future of AI in medicine and want to see how tech and trading intersect, this video is for you. Hit that subscribe button and stay tuned for more insights! #AI #MedicalAI #ChatGPT #MedicalExam #OVTLYR #StockMarket #MicrosoftStock #TradingSignals #DrScottGottlieb #AIInsights #InvestmentTips

Dr. Scott Gottlieb returns! The former FDA Commissioner gives us a deep dive into the revolutionary advances in cell/gene therapies and other treatments that have the potential to cure cancer, reverse aging, and re-engineer our DNA. We also discuss the emerging role of AI in healthcare and get a bit wonky discussing regulatory hurdles at the FDA. A must-listen for anyone interested in the future of healthcare, the impact of policy on medical innovation, and the exciting possibilities of gene and cell therapy.  Dr. Scott Gottlieb served as the twenty-third commissioner of the FDA under President Trump. He is a resident fellow at the American Enterprise Institute and author of the forthcoming book “The Miracle Century: Making Sense of the Cell Therapy Revolution.” Follow him on X at @ScottGottliebMD.

The government's role in public health is a hot-topic discussion in a world dedicated to scientific advancement and safety. Today's episode discusses the Food and Drug Administration's role in promoting and protecting public health, the goals needed to cure disease on a national and worldwide scale, and the essential qualities of public health leadership. We sat down with former Commissioner of the FDA and renowned cancer specialist Dr. Andrew von Eschenbach to dive into the process and policy. Dr. Andrew von Eschenbach is the former Commissioner of the Food and Drug Administration and Director of the National Cancer Institute at the National Institutes of Health. He served as the Executive Vice President and Chief Academic at the University of Texas M.D. Anderson Cancer Center as well as Chairman of the Department of Urologic Oncology. Dr. von Eschenbach is an internationally renowned cancer specialist and served as a Lt. Commander in the U.S. Navy Medical Corps.(02:37) – An interest in science(05:04) – Investigating and treating cancer(09:04) – National Cancer Institute (12:17) – Public policy and healthcare leadership(15:57) – Food and Drug Administration(19:06) – Joining the agency(23:25) – Promote and protect public health(30:59) – Leadership in process and policy, not practice(33:52) – Increasing interest in supplements(38:43) – Personalized medicine and digital health(43:01) – An issue of trust(47:36) – Engaging real-world evidence(49:39) – Innovation in the delivery of care infrastructureIf there are topics that you are interested in learning more about, please visit MichaelJLeeMD.com.If you'd like to receive new episodes as they're published, please follow I'd Love to Know in Apple Podcasts, Spotify, or wherever you get your podcasts. If you enjoyed this episode, please consider leaving a review on Apple Podcasts or Spotify. It really helps others find the show.The information from this podcast does not constitute medical advice and is meant for basic informational purposes only. If you're interested in pursuing any of the therapies, supplements, or medications discussed here, please consult with your physician.Podcast episode production by Dante32.

In this week's Parallax episode, Dr Ankur Kalra welcomes Dr Haider Warraich, a cardiologist at Brigham and Women's Hospital. Dr Warraich is not only a Senior Advisor for Chronic Disease to the FDA Commissioner but also a prolific author, having written three books, including "Song of Our Scars: The Untold Story of Pain." He is a regular contributor to publications like the New York Times and the Washington Post. During the conversation, we learn more about Dr Warraich's journey into medicine and his current role at the FDA, along with his passion for writing. Dr Kalra asks about how Dr Warraich manages his busy schedule and what it takes to write a book. Dr Warraich openly shares his personal experience grappling with chronic pain, a pivotal event that not only influenced his career trajectory but also inspired his book "Song of Our Scars." Moreover, he discusses his role as a Senior Advisor to Dr Robert M Califf, offering insights into his day-to-day responsibilities within the FDA. The conversation also touches upon the agency's perspective on emerging technologies like artificial intelligence (AI). How does writing complement Dr Warraich's work as a physician? How did he become a senior advisor to Dr Robert M Califf at the FDA? What is his message to our listeners?

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in the Pharma and Biotech world. AstraZeneca, the pharmaceutical company, recently had its day in court regarding a potential injunction on the Medicare drug pricing law. The outcome of the hearing will have significant implications for the healthcare industry. Meanwhile, Vertex Pharmaceuticals' non-opioid pain drug failed to outperform Vicodin in clinical trials, but experts believe that more can be done to develop effective non-opioid pain medications. In other news, a study has found that the Inflation Reduction Act's drug price negotiation program will have only a modest impact on global biopharma revenues and is unlikely to result in significant cuts to research and development. Sanofi reported a $600 million net loss in Q4 2023 due to various factors, despite strong sales of its blockbuster drug Dupixent. Additionally, Roche's 2024 strategy aims to combat low growth through pipeline cuts and mergers and acquisitions. Daiichi Sankyo has raised its sales forecast for Enhertu due to non-US growth, and the FDA Commissioner has highlighted adcomm reform, funding, and AI as priorities for the agency.Moving on to other industries, Pepsi is generating excitement for the Super Bowl with its "Get Wild" campaign for Pepsi Wild Cherry. Gatorade, another brand under PepsiCo, is launching a free membership platform to fuel its digital transformation. Jif, the peanut butter brand, is tackling "celery neglect" on game day by offering free peanut butter through a tie-up with Gopuff. In social media news, CEOs faced tough questions about child protection in a Senate session, with senators arguing that social platforms need to do more to protect young users. Advertiser Perceptions' Erin Firneno advises media companies on how to communicate brand momentum in 2024. The Super Bowl LVIII ads are being tracked, with reveals from Michelob Ultra and Paramount+, and teasers from Uber and Nyx. Google, CrowdStrike, and State Farm will also be returning with ads. Lastly, Marketing Dive's daily newsletter offers insights and news for marketing leaders.In the field of research, BioIVT is a leading provider of control matrices, offering biofluids, tissues, and matrices from commercial animals for research purposes. These biospecimens undergo strict quality control measures to enhance assay sensitivity. BioIVT offers a wide range of control matrices, including serum, cerebrospinal fluid (CSF), ocular fluid, and various tissues. These samples can be shipped fresh, cold, or frozen to ensure reliability and quality. Additionally, BioIVT provides matrices from commercial animals.Thank you for listening to Pharma and Biotech daily. Stay tuned for more important updates in the world of Pharma and Biotech.

Making his return to the show is Dr. Robert Califf, the current FDA Commissioner, this time to break down and offer insights into the Administration's contentious accelerated approval pathway. Dr. Califf expands on the criticisms and concerns surrounding surrogate endpoints and confirmatory trials within the accelerated approval process, shedding light on the ongoing dialogue between the Administration and manufacturers regarding these crucial trials. He navigates through the intricacies of the Food and Drug Omnibus Reform Act, offering perspectives on the global use of drugs and devices post-negative results in confirmatory trials. Dr. Califf also emphasizes the imperative need for a revamped post-market evidence generation system while exploring various avenues for achieving this critical transformation. Check out Chadi's website for all Healthcare Unfiltered episodes and other content. www.chadinabhan.com/ Watch all Healthcare Unfiltered episodes on YouTube. www.youtube.com/channel/UCjiJPTpIJdIiukcq0UaMFsA

America Out Loud PULSE with Dr. Vaughn & Dr. Tankersley – The elites disregarded countless fundamental principles and panicked. Ultimately, they continue to give themselves an excuse for their criminal decisions that have resulted in such terrible outcomes. "All in the name of doing something because it was such a bad pandemic." As the FDA Commissioner, Robert Califf broke many protocols. He decided that advocating for...

America Out Loud PULSE with Dr. Vaughn & Dr. Tankersley – The elites disregarded countless fundamental principles and panicked. Ultimately, they continue to give themselves an excuse for their criminal decisions that have resulted in such terrible outcomes. "All in the name of doing something because it was such a bad pandemic." As the FDA Commissioner, Robert Califf broke many protocols. He decided that advocating for...

Wading through the torrent of information available online is challenging for everyone. It can be hard to know what and whom to believe. We talk with the FDA Commissioner and other leaders on the frontlines of health and science about how to be more aware of false and misleading information, and its risks to our wellbeing and future innovation. And we discuss ways to stand up for science and stop the spread of misinformation. 

Wading through the torrent of information available online is challenging for everyone. It can be hard to know what and whom to believe. We talk with the FDA Commissioner and other leaders on the frontlines of health and science about how to be more aware of false and misleading information, and its risks to our wellbeing and future innovation. And we discuss ways to stand up for science and stop the spread of misinformation. 

This week on Pharm5: Cost Plus Drug Co. adds Invokana products Gohibic (vilobelimab) EUA for COVID-19 Makena (hydroxyprogesterone caproate injection) withdrawn from market APL treatment oral tretinoin shortage Federal judge strikes down ACA's OCP and PrEP coverage     Connect with us! Listen to our podcast: Pharm5 Follow us on Twitter: @LizHearnPharmD   References: Mark Cuban CostPlus Drug Company - Medications. http://bit.ly/3KjKYS5. Accessed April 6, 2023. Invokana® (canagliflozin) affordability. Janssen CarePath for Healthcare Professionals. http://bit.ly/3nWANLm. Published October 18, 2022. Accessed April 6, 2023. Center for Drug Evaluation and Research. FDA authorizes Gohibic (vilobelimab) injection. U.S. Food and Drug Administration. http://bit.ly/3nWDsVm. Published April 4, 2023. Accessed April 6, 2023. Gohibic [highlights of emergency use authorization]. Jena, Germany: InflaRx GmbH. Published April 2023. Accessed April 6, 2023. FDA Commissioner and Chief Scientist announce decision to withdraw approval of Makena. U.S. Food and Drug Administration. http://bit.ly/3ZMOY35. Published April 6, 2023. Accessed April 6, 2023. Drug shortage detail: Tretinoin capsules. ASHP. https://bit.ly/3KhQ2pT. Published March 20, 2023. Accessed April 6, 2023. Treatment of acute promyelocytic leukemia (APL). American Cancer Society. http://bit.ly/3mb3Nif. Accessed April 6, 2023. Cingam SR, Koshy NV. Acute Promyelocytic Leukemia. National Center for Biotechnology Information. http://bit.ly/3nGw5RV. Accessed April 6, 2023. Phillips C. Help Desk for Oncologists Treating People with a Rare Leukemia Pays Big Dividends. National Cancer Institute. http://bit.ly/40EtxT3. Published February 2, 2023. Accessed April 6, 2023. Braidwood Management, Inc., et al. v. Xavier Becerra, et al. Civil Action No. 4:20-cv-00283-O. Supreme Court of Texas, 2022. Accessed April 6, 2023. Judge strikes down Obamacare provisions requiring insurers cover some preventive care services. NBCNews.com. https://bit.ly/3MncZKV. Published March 30, 2023. Accessed April 6, 2023. Burwell v. Hobby Lobby and birth control. Planned Parenthood Action Fund. http://bit.ly/419fPaq. Accessed April 6, 2023. Stolberg SG, Abelson R. Federal judge strikes down Obamacare requirement for free preventive care. The New York Times. http://bit.ly/3nSSAU1. Published March 30, 2023. Accessed April 6, 2023.

Dr. Robert Califf, commissioner of the U.S. Food & Drug Administration, discusses the promising research behind a new class of diabetes and obesity drugs that could improve tens of millions of lives in America impacted by the obesity epidemic. He addresses the FDA's pending new tobacco control rules, as well as improvements to the infant formula pipeline in the wake of recent shortages. Dr. Califf also voices deep concerns that health misinformation is the 'leading cause of death in America now.' Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

We hear from Ethan Lane, VP of governmental affairs at NCBA, about where things may be heading over WOTUS, response to the FDA Commissioner's statement on cell cultured meat, and the Paruguay beef import situation. Bret Walts of BAMWX.com joins us to talk weather, particularly potential dangerous conditions over the next 24-48 hours. And we learn about green methanol from Jeff Reints of Iowa.See omnystudio.com/listener for privacy information.

Recently, the Food and Drug Administration announced that retail pharmacies in the US would be able to receive certification to dispense medication abortion drugs. Greer Donley, Associate Professor at the University of Pittsburgh School of Law, sits down to talk with us about the FDA's recent changes to regulations around medication abortion, including the current status of access, possible challenges, and how far these new changes really go.   Since the FDA approval of mifepristone—one of two medications currently used in a medication abortion—in 2000, access has been harshly regulated. Usually, FDA-approved medications are easily prescribed by licensed providers and dispensed at a pharmacy, but mifepristone faces additional barriers, including a Risk Evaluation and Mitigation Strategies (REMS) protocol. REMS restrictions are reserved for dangerous medication, and include a certification process for the clinician, requires that the medication be dispensed in person in the clinic, hospital, or medical office, and that patients must fill out a consent form. Every major medical association and major expert in the field has branded REMS restrictions for mifepristone completely unnecessary, as it is an incredibly safe drug to take—safer than Penicillin, Viagra, and Tylenol.  During the pandemic, the FDA temporarily lifted the in-person restriction, as making people physically go pick-up medication abortion pills put them at unnecessary risk of COVID-19 transmission. The Supreme Court overturned this decision, but the Biden administration's newly elected FDA Commissioner, in response, announced that they would not enforce the in-person dispensing requirement completely. A few weeks ago, the FDA began formalizing this announcement, laying out the reversal of in-person dispensing requirement and the allowance of some pharmacies to dispense medication abortion after a certification process. These changes will not have any effect in states that currently ban abortion, as state laws will stop pharmacies and prescribers from dispensing mifepristone. Even with the formalization of this rule, it is unclear how many pharmacies will go through the certification process to be able to dispense the drug. In addition, once pharmacies do become certified, patients will still need to find a certified provider to write than a prescription, and states will still have to follow state laws that restrict abortion. There is a current legal challenge working its way through district court which would ban access to mifepristone. This case was incited by an anti-abortion group suing the FDA in Texas in an effort to revive the Comstock Act; this act, passed near 150 years ago, bans mailing “obscene materials,” the definition of which is being applied to abortion pills. This lawsuit is completely meritless, yet it is still making its way through district court where the only judges are anti-abortion Trump-appointees. In the U.S., more than 50 percent of abortions are medication abortion, and with Dobbs' disruption of abortion care, this will be incredibly harmful to access post-Roe. Support the showFollow Us on Social: Twitter: @rePROsFightBack Instagram: @reprosfbFacebook: rePROs Fight Back Email us: jennie@reprosfightback.comRate and Review on Apple PodcastThanks for listening & keep fighting back!

It's an all doctor episode! The FDA Commissioner joins Sean and Priyanka to discuss the importance of getting vaccinated this flu season. Dr. Drew is on the podcast! From Loveline to Ask Dr. Drew, he shares all about his career and his prostate cancer diagnosis.

Throughout COVID-19, the FDA has been among many government agencies charged with communicating lifesaving information. Commissioner Dr. Robert Califf talks with Dr. Josh Sharfstein about how the politicization of the pandemic raised the stakes for the FDA and how the agency is learning to adapt in an age of rampant misinformation. They also discuss the FDA's consideration of bivalent vaccines for authorization and what's next for the pandemic response. 

The unknown health effects of e-cigarettes and vaping products have long been discussed but recently the Food and Drug Administration has announced plans to remove all products from the popular e-cigarette company Juul from shelves due to insufficient public health data. This past week, the FDA dropped their suspension of Juul and the Juul company agreed to suspend their court case while the government reopens its investigation into the company's products. Earlier this week, former FDA Commissioner Dr. Scott Gottlieb joined the podcast to break down the thought process behind the FDA's initial decision, the effect this could have on smokers attempting to quit, and how this could deter youth from vaping. Due to time limitations, we could not include all of the interview in our original segment. Today on the FOX News Rundown Extra, you will hear our entire interview with Dr. Gottlieb about this decision and how it could impact the vaping and tobacco industry. Learn more about your ad choices. Visit megaphone.fm/adchoices

Tonight, we look at Turkey opposing Sweden and Finland's bid to join NATO. The FDA Commissioner getting grilled on when baby formula will return to shelves. The new collection at the National Gallery of Art giving viewers a global journey through Black history. 

Lawmakers on both sides of the aisle pressed the FDA Commissioner on the baby formula shortage; The suspect in the Buffalo mass shooting in court today, with grieving families of the victims; CDC Panel recommending Pfizer booster shots for children five to eleven; President Biden welcomes new NATO bids, Finland and Sweden; The first case of Monkeypox in the US this year. Learn more about your ad choices. Visit megaphone.fm/adchoices

7:04-NEWS 7:10-NPR sets up a "snitch hotline" for violations of their mask guidelines  7:25- Another spin-off "Yellowstone" is coming  7:30-Biological female skateboarder speaks out against Red Bull for allowing a transgender female to compete who ended up winning the competition.  7:45- CUT SHEET | The Late Show With Stephen Colbert welcomes Secretary of State Tony Blinken on the show | Biden's weird analogy for Sweden and Finland wanting to join NATO | Pelosi says she's happy with Biden's response to the formula shortage | FDA Commissioner says it will be a few weeks before the supply is back up | Senator Gillibrand blames corporate greed for the baby formula shortage |  Photo: Getty Images

6:04-NEWS 6:10-Voting against $40 billion in aid to Ukraine doesn't mean you're pro-Russia  6:40-Is an elephant a person?  6:51-Netflix scraps woke projects  7:04-NEWS 7:10-NPR sets up a "snitch hotline" for violations to their mask guidelines  7:25- Another spin-off "Yellowstone" is coming  7:30-Biological female skateboarder speaks out against Red Bull for allowing transgender a female who ended up winning the competition.  7:45- CUT SHEET | The Late Show With Stephen Colbert welcomes Secretary of State Tony Blinken on the show | Biden's weird analogy for Sweden and Finland wanting to join NATO | Pelosi says she's happy with Biden's response to the formula shortage | FDA Commissioner says it will be a few weeks before the supply is back up | Senator Gillibrand blames corporate greed for the baby formula shortage |  8:07-People are getting monkey-pox  8:23-NEWS 8:35-Biden Administration and other governments are preparing to enter a "Global Pandemic" treaty with the World Health Organization.  9:04-NEWS 9:08- Update on the U.S. Senate race in Pennsylvania for a Republican nominee  9:12-Senator Tom Massie is the lone vote against a censorship bill   9:42-CUT SHEET | All 50 states have surpassed an average of $4/gallon of gas | CNN's feature on the insane gas price rises | Interior Secretary won't say if gas prices are too high when asked during hearing | She also couldn't explain the decision to shut down oil production | Expect gas prices to go up more | Pelosi believes abortion is a kitchen table issue  9:55-Final Thoughts 

Many parents with young children have one question: When will my kid be eligible for a COVID-19 vaccine? They got one step closer to an answer this week, when Moderna filed an Emergency Use Authorization for a vaccine the company says is safe and effective for kids ages 6 months through 5 years. FDA Commissioner Robert Califf tells Andy what's holding up approval, why getting the dose right is so critically important, and whether rumors that the FDA would wait for data on a three-dose vaccine from Pfizer before clearing a two-dose vaccine from Moderna are true. Keep up with Andy on Twitter @ASlavitt and Instagram @andyslavitt.  Follow Robert Califf on Twitter @DrCaliff_FDA. Joining Lemonada Premium is a great way to support our show and get bonus content. Subscribe today at bit.ly/lemonadapremium.    Support the show by checking out our sponsors! Click this link for a list of current sponsors and discount codes for this show and all Lemonada shows: https://lemonadamedia.com/sponsors/  Throughout the pandemic, CVS Health has been there, bringing quality, affordable health care closer to home—so it's never out of reach for anyone. Because at CVS Health, healthier happens together. Learn more at cvshealth.com.   Check out these resources from today's episode:  Find vaccines, masks, testing, treatments, and other resources in your community here: https://www.covid.gov/ Order Andy's book, Preventable: The Inside Story of How Leadership Failures, Politics, and Selfishness Doomed the U.S. Coronavirus Response: https://us.macmillan.com/books/9781250770165  Stay up to date with us on Twitter, Facebook, and Instagram at @LemonadaMedia.  For additional resources, information, and a transcript of the episode, visit lemonadamedia.com/show/inthebubble. See omnystudio.com/listener for privacy information.

Two members of President Trump's Opening Our Country Council, Dr. Scott Gottlieb, former FDA Commissioner, and Steve Forbes, chairman and editor-in-chief of Forbes Media, join us this week to discuss how to save businesses around the country, the consequences of the lockdowns, the amount of risk to anticipate when going back to work, the effectiveness of testing and contact tracing, how asymptomatic carriers affect us, and much more. Become a Daily Wire member today to hear the bonus questions! Visit dailywire.com/Shapiro Learn more about your ad choices. Visit podcastchoices.com/adchoices